Guangshengtang: There may be a risk of a significant increase in the stock price of the company followed by a fall.

Guangshengtang disclosed a stock trading abnormality announcement on the evening of July 31. According to the latest data from China Securities Index Co., Ltd., as of July 30, 2025, the company's latest price-to-book ratio was 46.58; the latest price-to-book ratio of the industry category "pharmaceutical manufacturing industry" to which the company belongs was 3.17. The company's price-to-book ratio is significantly different from that of the same industry. The company's stock price has risen sharply in the short term, but the company's fundamentals have not undergone significant changes. There may be a risk of a sharp decline in stock price after a sharp rise. It is solemnly reminded that investors pay attention to the risks of the company's stock secondary market trading, make rational decisions, and invest cautiously.